IQVIA COVID-19 April briefing: A deep dive on impacts for UK&I pharma + biotech

Overview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications for the healthcare ecosystem. In the global effort to proactively fight COVID-19, the webinar series has been designed to: •Provide some areas which pharma and biotech companies may wish to consider around the COVID-19 outbreak, in order to help guide our community through uncertain times •Share key healthcare impact learnings from those countries that are ahead in the COVID-19 curve •Look at how we can, together, best support patients, healthcare professionals, life sciences and governments to reduce the impact of the virus This April webinar will take place on Thursday 23rd April from 12.30 to 13.30 (BST) / 07:30 to 08:30 (EST). You can listen to our March webinar here: https://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/ Focus During the April instalment, our expert panel will discuss: •Assessing the pharmaceutical market impact of COVID-19 •The UK clinical trials on COVID-19: navigating uncharted waters •Genomics: research in the time of COVID-19 •Knowledge sharing: the COVID-19 experience from a US perspective •Getting clinical research back up and running post-coronavirus •Adjustments to new medicine launch planning